Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,169-3,180 of 10,612

Drug study icon

CompletedNCT01876719

AR08 for Treatment of ADHD in Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Arbor Pharmaceuticals, Inc.
Condition: ADHD

Device study icon

CompletedNCT04075890

Arbitration Between Habitual and Goal-directed Behavior in OCD: Circuit Dynamics and Effects of Noninvasive Neurostimulation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDeviceFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: OCD

Drug study icon

CompletedNCT00489866

Aripiprazole Augmentation of Antidepressants in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Durham VA Medical Center
Condition: PTSD

Drug study icon

CompletedNCT02918370

Aripiprazole for Bipolarity and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Bipolarity, Addiction

Drug study icon

CompletedNCT00181779

Aripiprazole for Mania in Children and Adolescents With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity

Drug study icon

CompletedNCT00102063

Aripiprazole in Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00110461

Aripiprazole in Children and Adolescents With Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT00095511

Aripiprazole in people with Acute Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT00095810

Aripiprazole in people with Psychosis Associated With Parkinson's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 50 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00226317

Aripiprazole in the Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Cambridge Health Alliance
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00374348

Aripiprazole in the Treatment of people with Schizophrenia and Symptoms of OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCD, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Jamaica Hospital Medical Center
Condition: OCD, Schizophrenia

Drug study icon

TerminatedNCT04203056

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, DepressionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Schizophrenia, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.